dtb.bmj.comDrug and Therapeutics Bulletin (DTB) | DTB provides independent evaluations of treatments and the ov

Subscribe Log In Advanced search Search Latest content Current issue Archive Podcasts About Email alerts Intro Widget Drug and Therapeutics Bulletin is a peer-reviewed journal that provides independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals. DTB summarises the best available evidence to enable readers to make informed and unbiased choices regarding medicines and other treatments to help patients get the best care. DTB content includes opinion pieces, commentaries, summaries of recently published evidence as well as clinical reviews and articles on new medicines. Drug and Therapeutics Bulletin adheres to the highest possible industry standards concerning publication ethics. Content is commissioned and undergoes a rigorous and transparent editorial process. DTB is also wholly independent of the pharmaceutical industry, Government and regulatory authorities and is also free of advertising and other forms of commercial sponsorship. Drug and Therapeutics Bulletin publishes regular podcasts discussing highlights from its issues. Subscribe in all podcast platforms, including Apple Podcasts , Google Podcasts , Stitcher and Spotify . Highlighted Articles Highlighted Articles Self-monitoring blood glucose in non-insulin type 2 diabetes 12 February, 2020 Still no place for depot triamcinolone in hay fever? 12 February, 2020 Are patient education materials for deprescribing fit for purpose? 12 February, 2020 No benefit from amitriptyline for chronic low back pain? 23 January, 2020 Altmetrics Podcasts Latest Articles Editorial: Dapagliflozin for type 1 diabetes: ensuring benefits outweigh the risks 26 February, 2020 DTB Select: Community pharmacy interventions and health outcomes 26 February, 2020 DTB Select: Ursodeoxycholic acid offers no benefit in obstetric cholestasis 26 February, 2020 Review: Prescribing for pregnancy: asthma 26 February, 2020 DTB Select: Are patient education materials for deprescribing fit for purpose? 12 February, 2020 DTB Select: Self-monitoring blood glucose in non-insulin type 2 diabetes 12 February, 2020 DTB Commentary: High-dose PPI and aspirin as chemoprevention in Barrett’s oesophagus 16 January, 2020 Republished “[case report]”: Republished: Partial nephrogenic diabetes insipidus associated with lithium therapy 29 November, 2019 Most Read Articles Review: How to communicate evidence to patients 25 July, 2019 Editorial: Registering our interest 30 January, 2020 DTB Select: Are patient education materials for deprescribing fit for purpose? 12 February, 2020 Review: Melatonin for jet lag 13 January, 2020 DTB Select DTB SELECT: Community pharmacy interventions and health outcomes 26 February, 2020 DTB SELECT: Ursodeoxycholic acid offers no benefit in obstetric cholestasis 26 February, 2020 DTB SELECT: Are patient education materials for deprescribing fit for purpose? 12 February, 2020 DTB SELECT: Self-monitoring blood glucose in non-insulin type 2 diabetes 12 February, 2020 DTB SELECT: MHRA guidance on assessing renal function 10 December, 2019 About All content in DTB is commissioned and undergoes a rigorous and transparent editorial process: articles are peer-reviewed externally and internally, authors and DTB Editorial members are required to declare and publish any conflicts of interest. DTB publishes reviews, editorials, select summaries and case reports. Read more about our content in the Welcome to the new Drug and Therapeutics Bulletin Editorial . Editorial policies Publication information Related Journals European Journal of Hospital Pharmacy Current issue Visit this journal BMJ Evidence-Based Medicine Current issue Visit this journal BMJ Quality & Safety Current issue Visit this journal Twitter Feed DTB_BMJ @DTB_BMJ DTB Select - Can a point-of-care CRP test reduce antibiotic use in COPD? https://t.co/gN24Vz7aiX View on Twitter 0 0 DTB_BMJ @DTB_BMJ DTB Select - No benefit of faecal microbiota transplantation for IBS-D. https://t.co/WONLALgBi1 https://t.co/gY2yIGA0Di View on Twitter 0 0 DTB_BMJ @DTB_BMJ DTB Select - EMA suspends licence for ingenol mebutate (Picato). https://t.co/iuCiiZrVBR https://t.co/vDGbBYHCzB View on Twitter 0 0 DTB_BMJ @DTB_BMJ DTB Select - EMA suspends licence for ingenol mebutate (Picato). https://t.co/gdo4qe0NyB https://t.co/QNkIMdoGJa View on Twitter 0 0 DTB_BMJ @DTB_BMJ DTB Review - Still no place for depot triamcinolone in hay fever? https://t.co/UCDmUzo7OQ https://t.co/SdCwX5ERYq View on Twitter 0 0 DTB_BMJ @DTB_BMJ DTB Review - What is the evidence for the use of potassium permanganate for wound care? https://t.co/XmbRmBVhwV https://t.co/ixCSdUjrcd View on Twitter 0 0 See More -- Content Latest content Browse by topic Most read articles Responses Journal About Editorial policies Editorial board Thank you to our reviewers Subscribe Publication information Subscribe Email alerts Log in Help Contact us Reprints Permissions Feedback form Website Terms & Conditions Privacy & Cookies Contact BMJ Online ISSN: 1755-5248 Print ISSN: 0012-6543 Copyright © 2020 BMJ Publishing Group Ltd. All rights reserved. 京ICP备15042040号-3 Cookie Settings...